Close Menu

Grants

Additional funding opportunities

Research Funding Opportunities

Tools to Find Funding

Grants Awarded for Health Sciences Research

Title Typesort descending $ Amount Activity Investigator Unit Sponsor Date
VA Medical Educational Costs Ancillary Contract - Residency Programs $61,636.00 Instruction Conrad Clemens COM Academic Affairs United States Department of Veterans Affairs 06/2021
Rapid Immunoassay for Diagnosis of Coccidioidomycosis Contract $49,999.00 Research John Galgiani Valley Fever Ctr for Excellnc DxDiscovery 09/2020
Work Order to the Master Subaward Agreement for Non-Industry Funding Sources between Public Health Institute (PHI) Contracting on behalf of the Children's Oncology Group (COG) Contract $750,000.00 Clinical Trial Holly Pariury Cancer Center Division Public Health Institute 03/2022
Product Development of the Vertical Integrated Flow Assay System Technology ("VERIFAST") for Multiplex Pathogens Detection Contract $4,364,034.00 Research Frederic Zenhausern COM Phx NanoBioscience & Med Advanced Technology International 04/2020
A Phase 3 Open-label Study Evaluating the Longterm Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor Triple Combination Therapy in Cystic Fibrosis Subjects 2 Years and Older Contract $484,469.00 Clinical Trial Cori Daines Asthma/Airway Disease Rsch Ctr Vertex Pharmaceuticals, Incorporated 02/2022
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Effect of Omecamtiv Mecarbil on Exercise Capacity in Subjects with Heart Failure with Reduced Ejection Fraction... Contract $105,851.40 Clinical Trial Aaron Wolfson Sarver Heart Center Cytokinetics, Incorporated 09/2020
Carmat Total Artificial Heart Early Feasibility Study Contract $236,322.20 Clinical Trial Radha Gopalan COM Phx Internal Medicine Carmat (FRANCE) 03/2021
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of a Single Dose of Exebacase in Patients Receiving Standard-of-Care Antibiotics for the Treatment of Staphylococcus aur Contract $82,971.76 Clinical Trial Tanya Anand Surgery ContraFect Corp 01/2022
Clinical Study of the BioVentrix Revivent TC System for Treatment of Left Ventricular Aneurysms Contract $194,732.72 Clinical Trial Ashish Pershad COM Phx Internal Medicine BioVentrix, Inc. 08/2020
Prognostic Gene Expression Profiling and Adjuvant Therapy in Stage IIIA-B Cutaneous Melanoma (PERSONALize) Contract $146,718.00 Clinical Trial Jennifer Erdrich Cancer Center Division Castle Biosciences Incorporated 02/2021
An Open-label, Phase 1, First-in-human, Dose Escalation and Expansion Study to Evaluate the Safety, Tolerability, Maximum Tolerated or Administered Dose, Pharmacokinetics, Pharmacodynamics and Tumor.. Contract $2,247,249.52 Clinical Trial Ricklie Julian Cancer Center Division Bayer Pharmaceutical 04/2021
A Phase II, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety and Tolerability of MEDI3506 in Participants with Moderate to Severe Chronic Obstructive Pulmonary Disease Contract $164,816.08 Clinical Trial Eugene Bleecker Asthma/Airway Disease Rsch Ctr Medimmune, Incorporated (United Kingdom) 12/2021
COVID-19 Vaccines for Urban Dwelling American Indians Contract $858.35 Other Sponsored Activity Ronald Sorensen Family and Community Medicine Tucson Indian Center 06/2021
National Curriculum in Developmental Medicine ("NCIDM") Project Contract $25,000.00 Other Sponsored Activity Tamsen Bassford Family and Community Medicine American Academy of Developmental Medicine & Dentistry 03/2020
IPA Agreement for Dr. Ashwani Gupta Contract $75,884.00 Research Ashwani Gupta Surgery United States Department of Veterans Affairs 07/2020
UA-Altbach-Body-NAFLD-MR-2021 Contract $48,344.00 Research - Industry (62.5% MTDC) Maria Altbach Medical Imaging Siemens Medical Solutions USA 10/2021
Chemotherapy Induced Peripheral Neuropathy Natural History Study (EPIPHANY) Contract $159,936.00 Clinical Trial Pavani Chalasani Cancer Center Division IQVIA RDS Inc. 02/2020
Elecestrant Monotherapy VS. Standard Of Care For The Treatment Of Patients With ER+/HER2- Advanced Breast Cancer Following CDK4/6 Inhibitor Therapy: A Phase 3 Randomized, OPEN-LABEL, Active-Controlled Contract $369,650.07 Clinical Trial Pavani Chalasani Cancer Center Division Radius Health, Inc. 02/2020
Research on Arizona's Response to Sexual Violence Against Children and Adults with Intellectual and Developmental Disabilities Contract $99,829.00 Research Lynne Tomasa Family and Community Medicine Arizona Developmental Disabilities Planning Council 06/2020
SBIR OTA FA8649-20-9-9145 Raman COVID screener Contract $70,000.00 Research Kurt Denninghoff Dept of Emergency Medicine Botanisol Analytics, Inc. 09/2020
Work Order to the Master Subaward Agreement for Non-Industry Funding Sources between Public Health Institute, Contracting on behalf of The Children's Oncology Group Contract $750,000.00 Clinical Trial Holly Pariury Cancer Center Division Public Health Institute 03/2022
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate Sotatercept When Added to Background Pulmonary Arterial Hypertension (PAH) Therapy in Newly Diagnosed Intermediate- and High-r Contract $930,117.52 Clinical Trial Franz Rischard Medicine Acceleron Pharmaceuticals 02/2022
The Automated Diseases Activity Monitoring System (ADAMS) Contract $824,548.00 Research - Industry (62.5% MTDC) Frederic Zenhausern COM Phx NanoBioscience & Med Costa Devices Limited 10/2020
A Master Protocol Assessing the Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for the Treatment of Hospitalized Patients with COVID-19 Contract $450,320.00 Clinical Trial Marilyn Glassberg Csete COM Phx Internal Medicine Regeneron Pharmaceuticals, Inc 12/2020
Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia (The PROMISE II Trial) Contract $251,024.00 Clinical Trial Wei Zhou Surgery LimFlow, Inc. 02/2022

Pages